Home-Administered Trial of Direct Current Stimulation
Not Applicable
Completed
- Conditions
- Major Depression
- Interventions
- Device: Soterix tDCS machine
- Registration Number
- NCT02894736
- Lead Sponsor
- The University of New South Wales
- Brief Summary
Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
- Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks
- Total MADRS score ≥ 20
Exclusion Criteria
- Diagnosis of any DSM-IV psychotic disorder
- History of drug or alcohol abuse or dependence in the preceding 3 months
- High suicide risk
- Clinically defined neurological disorder or insult
- Metal in the cranium or skull defects
- Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Active tDCS Soterix tDCS machine Soterix tDCS machine is used to administer active stimulation
- Primary Outcome Measures
Name Time Method Montgomery Asberg Depression Rating Scale for Depression (MADRS) 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Black Dog Institute
🇦🇺Randwick, Sydney, New South Wales, Australia